Memorandum of Understanding agreed between the General Pharmaceutical Council and the Joint Council for Cosmetic Practitioners

Together, the GPhC and JCCP have agreed to a working relationship which will be characterised by regular contact and open exchange of information to: 

  • Maintain patient safety and confidence in pharmacy services and pharmacy professionals
  • Support the sharing of information, intelligence, expertise and experience
  • Contribute to improving the regulatory oversight of pharmacy activities
  • Define the circumstances in which the two organisations will act independently.

Professor David Sines, CBE – Chair – JCCP said,

“We are aware that an increasing number of aesthetic pharmacists are now engaged in delivering non-surgical treatments. The JCCP is delighted to have signed this agreement with the GPhC which recognizes the JCCP educational, clinical and practice-based standards and puts in place clear operational arrangements for the exchange of information and for working together on fitness to practise cases.” 

Duncan Rudkin, Chief Executive of the GPhC said,

“We are pleased to have agreed this MoU with the JCCP and we are committed to implementing it. This MoU is part of our ongoing efforts to protect patients by collaborating with our partners and improving the sharing of information with the sector. This is particularly important as the scope and range of pharmacy services change at pace.” 

You can read a full copy of the MoU here.

Further information 
The JCCP and the GPhC intend that their working relationship will be characterised by:

  • Making decisions that promote patient and public safety
  • Sharing information, intelligence, expertise and experience
  • Cooperating openly and transparently with other
  • Respecting each other’s independent status
  • Using resources effectively and efficiently.

Where the JCCP encounters any concern which it believes falls within the remit of the GPhC, they will, at the earliest opportunity, convey the concern and relevant information to a named individual with relevant responsibility at the GPhC. 

In particular, the JCCP will refer to the GPhC:

  • Concerns and relevant information about a pharmacy professional which may call into question their fitness to practise in the applied area of non-surgical cosmetic practice (including hair restoration surgery) where a satisfactory resolution through the pharmacy professional’s employer has not been achieved.
  • Concerns and relevant information about pharmacy premises which may call into question systemic failings and/or whether the pharmacy owner is fit to own a registered pharmacy.   

The Pharmacy Order 2010 sets out the GPhC’s duty to protect the public who use pharmacy services and the services provided by pharmacy professionals. To facilitate this work, it is important that intelligence held by JCCP that could indicate that a pharmacy professional’s fitness to practise is impaired or that a pharmacy’s service(s) pose a risk to the people using pharmacy services and the public, is shared with the GPhC on a timely basis. Both organisations will operate in accordance with relevant data protection legislation (including the Data Protection Act 2018 and the General Data Protection Regulation (EU 2016/679)), the Human Rights Act 1998 and the common law duty of confidentiality.

Key contacts 

General Pharmaceutical Council
Rebecca Bellars 
Media and Public Affairs Manager
Becky.bellars@pharmacyregulation.org 
0203 713 7998 

The Joint Council for Cosmetic Practitioners
Professor David Sines, CBE
Chair – JCCP
David.Sines@jccp.org.uk
07787 002297